Henry Karanja

1.5k total citations
17 papers, 233 citations indexed

About

Henry Karanja is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Henry Karanja has authored 17 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in Henry Karanja's work include Mosquito-borne diseases and control (7 papers), Malaria Research and Control (7 papers) and Viral Infections and Outbreaks Research (6 papers). Henry Karanja is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Malaria Research and Control (7 papers) and Viral Infections and Outbreaks Research (6 papers). Henry Karanja collaborates with scholars based in United Kingdom, Kenya and Uganda. Henry Karanja's co-authors include Britta C. Urban, Evelyn Gitau, Kevin Marsh, Cleopatra K Mugyenyi, Agnes Gwela, Jean Langhorne, Eunice Nduati, John N. Gitonga, George M. Warimwe and Charles R. Newton and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Henry Karanja

16 papers receiving 231 citations

Peers

Henry Karanja

PHEOH

IMMUN

EPIDE

Nancy Nyakoe Kenya

Supranee Phanthanawiboon Thailand

Victor Yman Sweden

Vanessa C. Nicolete Brazil

Luzia Maria de‐Oliveira‐Pinto Brazil

Amal Gadalla United Kingdom

A Misra United States

Chengli Zeng China

Irene Ruberto United States

Christine Wong China

Nancy Nyakoe Kenya

Henry Karanja

207 ×1.5

PHEOH

62 ×0.7

37 ×0.6

IMMUN

17 ×0.6

23 ×0.9

EPIDE

Citations per year, relative to Henry Karanja Henry Karanja (= 1×) peers Nancy Nyakoe

Countries citing papers authored by Henry Karanja

Since Specialization

Citations

This map shows the geographic impact of Henry Karanja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Karanja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Karanja more than expected).

Fields of papers citing papers by Henry Karanja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Karanja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Karanja. The network helps show where Henry Karanja may publish in the future.

Co-authorship network of co-authors of Henry Karanja

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Karanja. A scholar is included among the top collaborators of Henry Karanja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Karanja. Henry Karanja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zalwango, Flavia, Henry Karanja, Gyaviira Nkurunungi, et al.. (2024). NIHR Global Health Research Group on Vaccines for vulnerable people in Africa (VAnguard): Concept and Launch event report. SHILAP Revista de lepidopterología. 3. 35–35. 3 indexed citations

Zalwango, Flavia, Henry Karanja, Gyaviira Nkurunungi, et al.. (2023). NIHR Global Health Research Group on Vaccines for vulnerable people in Africa (VAnguard): Concept and Launch event report. NIHR Open Research. 3. 35–35.

Ngetsa, Caroline, Victor Osoti, Henry Karanja, et al.. (2023). Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR. PLoS ONE. 18(2). e0280685–e0280685. 5 indexed citations

Jenkin, Daniel, Daniel Wright, Pedro M. Folegatti, et al.. (2023). Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial. The Lancet Infectious Diseases. 23(8). 956–964. 14 indexed citations

Nyagwange, James, Kennedy Mwai, Henry Karanja, et al.. (2022). Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases. 127. 11–16. 4 indexed citations

Otiende, Mark, Symon M. Kariuki, Donwilliams O. Omuoyo, et al.. (2022). Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study. PLoS Medicine. 19(5). e1003994–e1003994. 7 indexed citations

Nyagwange, James, Kennedy Mwai, Henry Karanja, et al.. (2021). Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations. Journal of Clinical Virology. 146. 105061–105061. 5 indexed citations

Otiende, Mark, Donwilliams O. Omuoyo, George Githinji, et al.. (2021). Endemic chikungunya fever in Kenyan children: a prospective cohort study. BMC Infectious Diseases. 21(1). 186–186. 19 indexed citations

Bottomley, Christian, Mark Otiende, Sophie Uyoga, et al.. (2021). Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels. Nature Communications. 12(1). 6196–6196. 13 indexed citations

10.

Wright, Daniel, Elizabeth Allen, M. Clark, et al.. (2020). Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein. iScience. 23(11). 101669–101669. 26 indexed citations

11.

Tuju, James, Margaret J. Mackinnon, Abdirahman I. Abdi, et al.. (2019). Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). PLoS Pathogens. 15(7). e1007870–e1007870. 5 indexed citations

12.

Gitau, Evelyn, James Tuju, Henry Karanja, et al.. (2014). CD4+ T Cell Responses to the Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Mild Malaria. The Journal of Immunology. 192(4). 1753–1761. 13 indexed citations

13.

Kariuki, Symon M., Evelyn Gitau, Samson Gwer, et al.. (2013). Value of Plasmodium falciparum Histidine-Rich Protein 2 Level and Malaria Retinopathy in Distinguishing Cerebral Malaria From Other Acute Encephalopathies in Kenyan Children. The Journal of Infectious Diseases. 209(4). 600–609. 20 indexed citations

14.

Olupot‐Olupot, Peter, Britta C. Urban, Julie Jemutai, et al.. (2013). Endotoxaemia is common in children with Plasmodium falciparummalaria. BMC Infectious Diseases. 13(1). 117–117. 25 indexed citations

15.

Gitau, Evelyn, Gilbert Kokwaro, Henry Karanja, Charles R. Newton, & Stephen A. Ward. (2013). Plasma and Cerebrospinal Proteomes From Children With Cerebral Malaria Differ From Those of Children With Other Encephalopathies. The Journal of Infectious Diseases. 208(9). 1494–1503. 16 indexed citations

16.

Gitau, Evelyn, James Tuju, Henry Karanja, et al.. (2012). T-Cell Responses to the DBLα-Tag, a Short Semi-Conserved Region of the Plasmodium falciparum Membrane Erythrocyte Protein 1. PLoS ONE. 7(1). e30095–e30095. 10 indexed citations

17.

Nduati, Eunice, Agnes Gwela, Henry Karanja, et al.. (2011). The Plasma Concentration of the B Cell Activating Factor Is Increased in Children With Acute Malaria. The Journal of Infectious Diseases. 204(6). 962–970. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact